MARUCCI, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.535
EU - Europa 5.726
AS - Asia 1.486
Continente sconosciuto - Info sul continente non disponibili 72
SA - Sud America 18
OC - Oceania 9
AF - Africa 7
Totale 19.853
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.122
PL - Polonia 1.483
CN - Cina 1.304
IT - Italia 1.054
DE - Germania 917
UA - Ucraina 500
SE - Svezia 478
GB - Regno Unito 459
CA - Canada 403
FR - Francia 337
FI - Finlandia 225
IE - Irlanda 115
EU - Europa 71
BE - Belgio 59
VN - Vietnam 34
IN - India 27
RU - Federazione Russa 27
KR - Corea 26
TR - Turchia 24
RO - Romania 21
IR - Iran 17
NL - Olanda 15
SG - Singapore 10
HK - Hong Kong 8
AU - Australia 7
MX - Messico 7
AR - Argentina 6
BR - Brasile 6
JP - Giappone 6
CH - Svizzera 5
AT - Austria 4
CZ - Repubblica Ceca 4
JO - Giordania 4
LB - Libano 4
PK - Pakistan 4
RS - Serbia 4
CL - Cile 3
DK - Danimarca 3
IL - Israele 3
NO - Norvegia 3
SA - Arabia Saudita 3
BD - Bangladesh 2
BG - Bulgaria 2
CO - Colombia 2
DZ - Algeria 2
ES - Italia 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
TH - Thailandia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AS - Samoa Americane 1
CM - Camerun 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
ID - Indonesia 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 19.853
Salva come PNG Salva come JPEG
Città #
Fairfield 1.501
Woodbridge 1.485
Jacksonville 1.210
Warsaw 1.148
Chandler 958
Houston 798
Ashburn 747
Ann Arbor 710
Wilmington 687
Seattle 627
Cambridge 545
Nanjing 404
Kraków 331
Toronto 282
San Mateo 186
Camerino 178
Düsseldorf 171
Lawrence 164
Princeton 164
Dearborn 158
Boardman 147
Columbus 139
Ogden 138
Nanchang 125
Beijing 120
Lachine 117
Dublin 113
London 112
Helsinki 87
Kunming 86
San Diego 75
Milan 70
Shenyang 64
Hebei 61
Tianjin 59
New York 57
Brussels 56
Jiaxing 41
Centro 37
Hangzhou 36
Venezia 36
Ningbo 35
Philadelphia 35
Changsha 33
Shanghai 32
Dong Ket 31
Hefei 30
Redwood City 30
Jinan 26
Los Angeles 26
Venice 26
Orange 25
Bremen 24
Norwalk 24
Falls Church 23
Guangzhou 23
Perugia 22
Nürnberg 21
Verona 19
Zhengzhou 18
Old Bridge 16
Auburn Hills 15
Scafati 15
Kocaeli 14
Lanzhou 14
Buffalo 13
Council Bluffs 13
San Francisco 13
Chicago 12
New Bedfont 12
Tappahannock 12
Tulsa 12
West Jordan 12
Changchun 11
Leawood 11
Horia 10
Ardabil 9
Bologna 9
Caserta 9
Hounslow 9
Mountain View 9
Scuola 9
Simi Valley 9
Buti 8
Indiana 8
Meppel 8
Münster 8
Naples 8
Sindelfingen 8
Taizhou 8
Washington 8
Detroit 7
Seoul 7
St Petersburg 7
Ascoli Piceno 6
Augusta 6
Fuzhou 6
Hanover 6
Kharkiv 6
Kilburn 6
Totale 15.122
Salva come PNG Salva come JPEG
Nome #
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 320
Overview on Radiolabel-Free in Vitro Assays for GPCRs 308
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 262
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 253
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 242
The G Protein-Coupled Receptor GPR17: Overview and Update 240
Pharmacological characterization of the GPR17 receptor dual profile 236
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 234
“Synthesis and α-Adrenoreceptor Blocking Properties of Phenoxybenzamine-Related (2-Chloroethyl)-(2,3-dihydrobenzo-[1,4] dioxin-2-ylmethyl)-(2-phenoxyethyl) Amines”. 230
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands 214
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: Structure-affinity/activity relationship at α1-adrenoceptor subtypes and at 5-HT1A receptors. 211
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 203
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 201
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 196
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 186
“New Pyridazinones: Synthesis and Correlation Between Structure and α-Blocking Activity”. 181
“1,3 Oxathiolane Muscarinic Ligands Modified at the Cationic Head”. 181
GPR17 receptor modulators and their therapeutic implications: review of recent patents 181
Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol: novel M4 muscarinic receptor antagonists 180
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 173
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2c serotonin receptors 169
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 169
Synthesis and antimuscarinic activity of derivatives of 2-substituted-1,3-dioxolanes 168
1,3-Dioxolane-based ligands as a novel class of alpha(1)-adrenoceptor antagonists 167
Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor 163
Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 163
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines 162
1,3-Dioxolane-based ligands as rigid analogues of Naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors. 162
Synthesis and alpha1-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin 159
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 157
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine 157
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 156
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 156
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A2A adenosine receptor binding site 153
Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 3. Effect of inserting the tetraamine backbone into a macrocyclic structure 150
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 150
null 149
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 149
New sensible method to quantize the intestinal absorption of receptor ligands 149
Synthesis and pharmacological characterization of enantiomerically pure muscarinic agonists: difluoromuscarines 148
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT(2B) receptor ligands. Synthesis and preliminary pharmacological evaluation 147
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 147
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 147
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives 147
Simplified analogues of Ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors 144
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 144
“Dialkylaminoalkyl Esters of 2,2 Diphenyl-2-Alkylthioacetic Acids: A New Class of Potent and Functionally Selective Muscarinic Antagonists”. 144
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 144
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 143
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 142
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 142
Synthesis and α1-antagonist activity of derivatives of 4-chloro-5-{4-[2-(2-methoxyphenoxy)-ethyl]-1-piperazinyl}-3(2H)-pyridazinone 142
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 141
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 141
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 141
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds 139
Determination of Muscarinic Agonist Potencies at M1 and M2 Muscarinic Receptors in a Modified Pithed rat Preparation 139
“Pharmacological Characterization of Muscarinic Receptor Subtypes in Rabbit Isolated Tissue Preparations” 139
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 139
“N,N-diethylaminoethanol and N-methyl-4-piperidinol Esters of 2,2-diphenyl-2-Ethylthioacetic Acid as Potent and Selective Muscarinic Antagonist”. 138
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 138
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 137
Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol 137
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure 136
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: The discovery of new functionally selective muscarinic agonists 136
Synthesis and pharmacological characterization of new chiral derivatives of muscarine and allo-muscarine 134
“Novel and Highly Selective Postsynaptic α-Adrenoreceptor Antagonists: Synthesis and Structure-Activity Relationships of Alkane-Bridged [4-(phenoxyethyl)-1-piperazinyl]-3 (2H)-pyridazinones”. 133
“Synthesis and Pharmacological Activity of Some New Pyridazinones”. 132
Highly chiral muscarinic ligands: The discovery of (2S,2 ' R,3 ' S,5 ' R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M-2 partial agonist 132
“Synthesis and α1-Antagonist Activity of New Prazosin-and Benextramine-Related Tetraamine Disulfides”. 132
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 132
Structure-Activity Relationships of Methoctramine-Related Polyamines as Muscular Nicotinic Receptor Noncompetitive Antagonists. 2. Role of Polymethylene Chain Lengths Separating Amine Functions and of Substituents on the Terminal Nitrogen Atoms. 131
Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine 130
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 130
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 130
Antiviral properties of deazaadenine nucleoside derivatives 128
Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonist 128
“Synthesis and Pharmacological Evaluation of Enantiomerically Pure 4-Deoxy-4-Fluoro-Muscarines”. 127
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 125
Adenosine receptor modeling: what does the A2A crystal structure tell us? 124
Molecular modulation of muscarinic antagonists. Synthesis and affinity profile of 2,2-diphenyl-2-ethylthio-acetic acid esters designed to probe the binding site cavity. 124
Polyamines may modulate both G protein-coupled receptors and G proteins. 124
Deoxamuscaroneoxime Devatives as useful Muscarinic Aginist to Explore the Muscarinic Subsite: Demox, Amodulator of Orthosteric and Allosteric Site at Cardiac Muscarinic M2 Receptors. 122
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 122
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer. 122
SAR Studies on the Potent and Selective Muscarinic Antagonist 2-Ethylthio-2,2-diphenylacetic Acid N,N-Diethylaminoethyl Ester 122
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 120
Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol 120
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes 118
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 118
(+)-Cyclazosin derivatives as α1-adrenoceptor antagonists 115
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 115
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics 115
Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl) pyrrolidine sulfoxide derivatives 115
Structure-Activity Relatioships Among Novel Phenoxybenzamine-Related Beta-Chloroethylamines. 114
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 106
(+)-Cyclazosin, a selective alpha1B-adrenoceptor antagonist: Functional evaluation in rat and rabbit tissues 103
“Enantiomers of 8-(tert-butylamino-2-hydroxypropoxy) 3,4-dihydro-3-oxo-2H-(1,4) Benzothiazine: Racemic Resolution, Chiral Synthesis and Biological Activity“. 102
Searching for cyclazosin analogues as alfa1B-adrenoceptor antagonists 101
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 99
Totale 15.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.808
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019902 0 0 0 0 0 0 0 0 0 0 424 478
2019/20204.524 548 206 445 855 245 406 374 414 297 270 159 305
2020/20213.898 208 358 256 301 259 362 633 95 321 189 559 357
2021/20221.989 190 479 39 103 101 67 100 154 145 231 148 232
2022/20232.346 258 122 85 387 263 315 13 147 391 122 172 71
2023/20241.193 253 103 112 59 71 121 88 104 201 71 10 0
Totale 20.317